EVI: 1,3-thiazole-2-sulfonamide
EVI is a Ligand Of Interest in 5JGT designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 5JGT_EVI_B_303 | 96% | 27% | 0.083 | 0.994 | 0.77 | 2.31 | - | 5 | 1 | 0 | 100% | 0.53 |
| 5JGT_EVI_B_302 | 83% | 11% | 0.117 | 0.976 | 1.31 | 3.04 | 1 | 3 | 0 | 0 | 100% | 0.2 |
| 3S77_EVI_B_1 | 93% | 6% | 0.091 | 0.987 | 0.78 | 4.35 | - | 2 | 0 | 0 | 100% | 1 |
